Godavari Drugs Limited (BOM:530317)
125.95
+0.95 (0.76%)
At close: Jun 17, 2026
Godavari Drugs Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 145.09 | 23.73 | 26.23 | 30.85 | 22.76 |
Cash & Short-Term Investments | 145.09 | 23.73 | 26.23 | 30.85 | 22.76 |
Cash Growth | 511.36% | -9.52% | -14.97% | 35.50% | 38.95% |
Accounts Receivable | 435.81 | 423.24 | 594.23 | 579.35 | 555.79 |
Other Receivables | - | 8.52 | 11.73 | 11.12 | 14.14 |
Receivables | 443.9 | 441.98 | 614.91 | 599.35 | 576.02 |
Inventory | 460.64 | 279.41 | 206.51 | 198.56 | 100.34 |
Other Current Assets | 68.33 | 42.5 | 37.16 | 41.31 | 44.23 |
Total Current Assets | 1,118 | 787.63 | 884.81 | 870.06 | 743.34 |
Property, Plant & Equipment | 868.46 | 625.55 | 450.05 | 339.85 | 267.41 |
Long-Term Investments | 0 | 1.13 | 1.13 | 1.02 | 1.02 |
Other Long-Term Assets | 17.89 | 16.46 | 11.55 | 3.4 | 2.34 |
Total Assets | 2,004 | 1,431 | 1,348 | 1,214 | 1,014 |
Accounts Payable | 347.14 | 287.06 | 316.27 | 246.73 | 433.17 |
Accrued Expenses | - | 4.07 | 8.58 | 5.87 | 3.7 |
Short-Term Debt | 393.87 | 377.33 | 444.58 | 430.25 | 85.61 |
Current Portion of Long-Term Debt | - | 27.18 | 21.45 | 23.5 | 27.29 |
Current Income Taxes Payable | 10.92 | 11.9 | 11.55 | 10.17 | 12.27 |
Other Current Liabilities | 99.51 | 23.37 | 17.57 | 20.57 | 15.57 |
Total Current Liabilities | 851.44 | 730.9 | 820 | 737.08 | 577.61 |
Long-Term Debt | 369.71 | 238.95 | 111.67 | 119.48 | 117.82 |
Pension & Post-Retirement Benefits | 7.17 | 8.26 | 7.56 | 7.14 | 7.23 |
Long-Term Deferred Tax Liabilities | 18 | 19.18 | 18.63 | 16.46 | 15.14 |
Other Long-Term Liabilities | - | - | - | 0 | 0 |
Total Liabilities | 1,246 | 997.3 | 957.86 | 880.16 | 717.8 |
Common Stock | 101.27 | 75.31 | 75.31 | 75.31 | 75.31 |
Additional Paid-In Capital | - | 106.32 | 106.32 | 106.32 | 106.32 |
Retained Earnings | - | 246.34 | 202.54 | 147.05 | 109.19 |
Comprehensive Income & Other | 656.72 | 5.5 | 5.5 | 5.5 | 5.5 |
Shareholders' Equity | 757.99 | 433.46 | 389.66 | 334.17 | 296.31 |
Total Liabilities & Equity | 2,004 | 1,431 | 1,348 | 1,214 | 1,014 |
Total Debt | 763.58 | 643.46 | 577.7 | 573.22 | 230.73 |
Net Cash (Debt) | -618.49 | -619.73 | -551.47 | -542.38 | -207.96 |
Net Cash Per Share | -81.07 | -82.35 | -73.25 | -72.06 | -27.63 |
Filing Date Shares Outstanding | 7.55 | 7.53 | 7.53 | 7.53 | 7.53 |
Total Common Shares Outstanding | 7.55 | 7.53 | 7.53 | 7.53 | 7.53 |
Working Capital | 266.52 | 56.73 | 64.81 | 132.98 | 165.73 |
Book Value Per Share | 100.42 | 57.56 | 51.74 | 44.38 | 39.35 |
Tangible Book Value | 757.99 | 433.46 | 389.66 | 334.17 | 296.31 |
Tangible Book Value Per Share | 100.42 | 57.56 | 51.74 | 44.38 | 39.35 |
Land | - | 22.67 | 0.33 | 0.33 | 0.33 |
Buildings | - | 56.5 | 56.5 | 44.59 | 44.59 |
Machinery | - | 415.1 | 411.92 | 417.9 | 450.75 |
Construction In Progress | - | 299.46 | 183.21 | 90.75 | 4.9 |